| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/24/1999 | EP0897917A1 Compounds for use in the preparation of antiretroviral enantiomeric nucleotide analogs |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897725A2 Therapy for staphylococcus aureus |
| 02/24/1999 | EP0897303A1 Inhibitors of farnesyl-protein transferase |
| 02/24/1999 | EP0789707A4 Amino acid nucleic acids |
| 02/24/1999 | EP0700440B1 Regulator of contact-mediated hemolysin |
| 02/24/1999 | CN1209134A Water soluble antibiotics |
| 02/24/1999 | CN1209133A Phospholipid derivatives of phosphono-carboxylic acids, prodn. and use as antiviral |
| 02/24/1999 | CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same |
| 02/24/1999 | CN1209069A Covalent lipit-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 02/24/1999 | CN1209067A Stabilisers for live vaccines |
| 02/24/1999 | CN1209065A Otic microbial combinations |
| 02/24/1999 | CN1209061A Hemoregulatory compounds |
| 02/24/1999 | CN1208769A Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
| 02/24/1999 | CN1208732A Anti Bacillus pyocyaneu Flugge vitelline immunoglobulin products and use thereof |
| 02/24/1999 | CN1208628A Traditional Chinese medicine bolus for treating pulmonary tuberculosis and method for preparing same |
| 02/24/1999 | CN1208627A Traditional Chinese medicine bolus for treating tuberculosis of lymphnode, and method for preparing same |
| 02/23/1999 | US5874591 Method for the preparation of (±)-calanolide A and intermediates thereof |
| 02/23/1999 | US5874578 Reacting purine salt with bis(2,3-protected hydroxymethyl)cyclobutane |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874565 Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus |
| 02/23/1999 | US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 02/23/1999 | US5874541 Immunoglobulin or fragment is modified such that heavy chain variable region have been replaced by specific sequence or amino acids of a heavy chain immunogloblin comprising two heavy polypeptide chain consisting of antigen binding site |
| 02/23/1999 | US5874478 Antiviral agents |
| 02/23/1999 | US5874413 Cytomegalo virus |
| 02/23/1999 | US5874403 Amino acid conjugates of cyclohexapeptidyl amines |
| 02/23/1999 | US5874303 Sustainable cell line for the production of Marek's disease vaccines |
| 02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
| 02/23/1999 | US5874287 Mutagenized DNA molecules encoding modified subunit a of Cholera-toxin |
| 02/23/1999 | US5874264 Retrovirus |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874089 Protecting against canine oral papillomavirus (copy) |
| 02/23/1999 | US5874088 Oral cholera vaccine from vibrio cholerae |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874079 Exposing said bacteria to a bactericidal-effective amount of an isolated type ii phospholipase a2 |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | CA1340402C Quinoline derivatives and processes for preparation thereof |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/20/1999 | CA2213385A1 Method of protecting against coccidiosis infections in poultry |
| 02/18/1999 | WO1999007860A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | WO1999007839A2 Immunoprotective influenza antigen and its use in vaccination |
| 02/18/1999 | WO1999007836A1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/18/1999 | WO1999007826A1 Novel lactic acid bacteria |
| 02/18/1999 | WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | WO1999007734A2 Hepatitis c inhibitor peptide analogues |
| 02/18/1999 | WO1999007733A2 Hepatitis c inhibitor peptides |
| 02/18/1999 | WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | WO1999007699A1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency |
| 02/18/1999 | WO1999007696A1 Quinolizine carboxylic acid derivatives |
| 02/18/1999 | WO1999007666A1 Amine derivatives and process for producing the same |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007409A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | WO1999007399A1 Pharmaceutical composition containing a mixed extract of phellodendron amurense ruprecht cortex and patrinia scabiosaefolia fisch. for treatment of hepatitis c |
| 02/18/1999 | WO1999007396A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | WO1999007384A1 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative |
| 02/18/1999 | WO1999007379A1 5,6-HETEROARYL-DIPYRIDO[2,3-b:3',2'-f]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
| 02/18/1999 | WO1999007342A1 Prolonged release active agent dosage form adapted for gastric retention |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2300439A1 Kinase activating dependent cyclin protein kinases, and their uses |
| 02/18/1999 | CA2300373A1 Immunomodulator exhibiting antimicrobial and antimycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as pulmonary chronic and non-specific conditions, sexually transmitted diseases and the resulting immuno-deficiency |
| 02/18/1999 | CA2300273A1 Amine derivatives and method for producing the same |
| 02/18/1999 | CA2299627A1 Novel lactic acid bacteria |
| 02/18/1999 | CA2299554A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | CA2298840A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/18/1999 | CA2295620A1 5,6-heteroaryl-dipyrido¬2,3-b:3',2'-f|azepines and their use in the prevention or treatment of hiv infection |
| 02/18/1999 | CA2294049A1 Hepatitis c inhibitor peptides |
| 02/18/1999 | CA2267066A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896582A1 Non-dendritic backbone peptide carrier |
| 02/17/1999 | EP0896534A1 Injection formulations of avermectins and milbemycins based on castor oil |
| 02/17/1999 | EP0896532A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals |
| 02/17/1999 | EP0896506A1 Methods for inducing immune responsiveness in a subject |
| 02/17/1999 | CN1208436A Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 02/17/1999 | CN1208416A Isooxacephem derivatives |
| 02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1207911A Antiviral veterinary medicine injection and its preparation |
| 02/17/1999 | CN1042132C 8-amino-10-(azabicycloalkyl)-pyrido (1,2,3-D,E) (1,3,4) benzoxadiazine derivatives |
| 02/17/1999 | CN1042130C 4-oxo-azetidin-2-sulfonic-acid-amide and salt of same, preparation and application of same |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872110 Heparin-like derivatives |
| 02/16/1999 | US5872107 Anticarcinogenic agents capture therapy for tumors |
| 02/16/1999 | US5872001 Lanthionine antibiotic compositions and methods |
| 02/16/1999 | US5871998 Gene expression in transformed eukaryotic host cell; genetic engineering |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871954 Acylation of peptide or protein by reacting with coenzyme a ester of an oxy- or thio-substituted fatty acid analog in presence of n-myristoyl transferase |
| 02/16/1999 | US5871933 Diagnosing, screening, and confirming infection with accuracy; vaccines |
| 02/16/1999 | US5871913 Forms a complex with a human immunodeficiency virus envelope glycoprotein |
| 02/16/1999 | US5871750 Leukotoxin vaccine compositions and uses thereof |
| 02/16/1999 | US5871749 Therapeutic treatment of H. pylori associated gastroduodenal disease |